Autoinjectors Market Size Worth $5.3 billion by 2026

Published Date: 7-Jan-2021

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Global Autoinjectors Market, published by KBV research, The Global Autoinjectors Market size is expected to reach $5.3 billion by 2026, rising at a market growth of 17.6% CAGR during the forecast period.

In 2019, Anaphylaxis segment held the largest market share of the autoinjectors market, owing to the growing incidence of rheumatoid arthritis also drives the demand for autoinjectors worldwide. The Rheumatoid Arthritis market would exhibit a CAGR of 16.4% during (2020 - 2026).

On the basis of end-user, the autoinjectors market is divided into hospitals & clinics and home care settings. The home care settings segment had the largest market share in the year 2019 and can largely be credited to the swift growth in the geriatric population in the world and the increasing requirement for cost-effective administration of drugs. The Hospitals & Clinics market is expected to witness highest CAGR of 18.3% during the forecast period.

North America led the market in the year 2019 and is anticipated to maintain its dominance throughout the foreseeable period. This can be accredited to technological advancements in medical devices, progressive healthcare infrastructure, and higher demand for quality products. The Asia Pacific market is estimated to grow at a CAGR of 19.1% during (2020 - 2026). Additionally, The Europe market would showcase a CAGR of 17.1% during the forecast period.

Structural Insights: https://www.kbvresearch.com/autoinjectors-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.

Global Autoinjectors Market Segmentation

By Type

  • Disposable autoinjectors
  • Reusable autoinjectors

By Application

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Other Applications

By End Use

  • Hospitals & Clinics
  • Home care settings

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Ypsomed AG
  • AbbVie, Inc.
  • Biogen, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Autoinjectors Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.